期刊
SEMINARS IN LIVER DISEASE
卷 40, 期 3, 页码 240-255出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0040-1708806
关键词
cirrhosis; hepatic venous pressure gradient; elastography; von Willebrand factor
资金
- European Association for the Study of the Liver
- Andrew K. Burroughs Short-TermTraining Fellowship of the European Association for the Study of the Liver
Noninvasive diagnostics for portal hypertension include imaging and functional tests, as well as blood-based biomarkers, and capture different features of the portal hypertensive syndrome. Definitive conclusions regarding their clinical utility require assessment of their diagnostic value in specific clinical settings (i.e., diagnosing a particular hemodynamic condition within a well-defined target population). Several noninvasive methods are predictive of clinically significant portal hypertension (CSPH; hepatic venous pressure gradient [HVPG]>= 10mmHg; the threshold for complications of portal hypertension); however, only a minority of them have been evaluated in compensated advanced chronic liver disease (i.e., the target population). Importantly, most methods correlate only weakly with HVPG at high values (i.e., in patients with CSPH). Nevertheless, selected methods show promise for diagnosing HVPG >= 16mmHg (the cut-off for increased risks of hepatic decompensation and mortality) and monitoring HVPG changes in response to nonselective beta-blockers or etiological treatments. Finally, we review established and potential future clinical applications of noninvasive methods.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据